XML 37 R26.htm IDEA: XBRL DOCUMENT
v3.23.2

Segment Information | 6 Months Ended
--- | ---
Jun. 30, 2023
Segment Reporting [Abstract] |
Segment Information | 18. SEGMENT INFORMATION The Company has three operating and reportable segments: Assessment, Permitting and Response, Measurement and Analysis and Remediation and Reuse. These segments are monitored separately by management for performance against budget and prior year and are consistent with internal financial reporting. The Company’s operating segments are organized based upon primary services provided, the nature of the production process, their type of customers, methods used to distribute the products and the nature of the regulatory environment. Segment Adjusted EBITDA is the primary measure of operating performance for all three operating segments. Segment Adjusted EBITDA is the calculated Co mpany’s Earnings before Interest, Tax, Depreciation and Amortization (“EBITDA”), adjusted to exclude certain transactions such as stock-based compensation, acquisition costs and fair value changes in financial instruments, amongst others. Beginning in the first quarter of 2023, the calculation of Segment adjusted EBITDA no longer adjusts for start-up losses and investment in new services as the Chief Operating Decision Maker (“CODM”) no longer reviews the Segment Adjusted EBITDA measure without these costs. The CODM does not review segment assets as a measure of segment performance. During the first quarter of 2023, the Company determined to sell one of its specialty service lines within the lab testing business (the "Discontinuing Specialty Lab"), whose performance has been sporadic and whose service offering is non-core to the Company’s business. The Company expects the sale process to be completed by December 31, 2023. The discontinuation of this specialty service line, which is part of the Company's Measurement and Analysis segment, did not represent a strategic shift that had (or will have) a major effect on the Company’s operations and financial results, therefore it did not meet the requirements to be classified as discontinued operations. Corporate and Other includes costs associated with general corporate overhead (including executive, legal, finance, safety, human resources, marketing and IT related costs) that are not directly related to supporting operations. Overhead costs that are directly related to supporting operations (such as insurance, software, licenses, shared services and payroll processing costs) are allocated to the operating segments on a basis that reasonably approximates an estimate of the use of these services. Segment revenues and Adjusted EBITDA consisted of the following:
|  | Three Months Ended June 30, |  |
|  | 2023 |  |  | 2022 |  |
|  |  |  |  | Segment |  |  |  |  |  | Segment |  |
|  | Segment |  |  | Adjusted |  |  | Segment |  |  | Adjusted |  |
|  | Revenues |  |  | EBITDA |  |  | Revenues |  |  | EBITDA(4) |  |
Assessment, Permitting and Response |  | $ | 61,411 |  |  | $ | 13,833 |  |  | $ | 50,037 |  |  | $ | 10,809 |  |
Measurement and Analysis |  |  | 50,055 |  | (1) |  | 10,789 |  |  |  | 42,224 |  | (1) |  | 7,047 |  | (3)
Remediation and Reuse |  |  | 47,635 |  |  |  | 6,043 |  |  |  | 47,649 |  |  |  | 7,056 |  |
Total Operating Segments |  |  | 159,101 |  |  |  | 30,665 |  |  |  | 139,910 |  |  |  | 24,912 |  |
Corporate and Other |  |  | — |  |  |  | (9,474 | ) |  |  | — |  |  |  | (8,399 | ) |
Total |  | $ | 159,101 |  |  | $ | 21,191 |  |  | $ | 139,910 |  |  | $ | 16,513 |  |
|  | Six Months Ended June 30, |  |
|  | 2023 |  |  | 2022 |  |
|  |  |  |  | Segment |  |  |  |  |  | Segment |  |
|  | Segment |  |  | Adjusted |  |  | Segment |  |  | Adjusted |  |
|  | Revenues |  |  | EBITDA |  |  | Revenues |  |  | EBITDA(4) |  |
Assessment, Permitting and Response |  | $ | 113,625 |  |  | $ | 28,099 |  |  | $ | 95,637 |  |  | $ | 20,432 |  |
Measurement and Analysis |  |  | 92,582 |  | (2) |  | 17,176 |  |  |  | 81,985 |  | (2) |  | 13,369 |  | (3)
Remediation and Reuse |  |  | 84,322 |  |  |  | 11,321 |  |  |  | 96,968 |  |  |  | 15,049 |  |
Total Operating Segments |  |  | 290,529 |  |  |  | 56,596 |  |  |  | 274,590 |  |  |  | 48,850 |  |
Corporate and Other |  |  | — |  |  |  | (18,802 | ) |  |  | — |  |  |  | (15,886 | ) |
Total |  | $ | 290,529 |  |  | $ | 37,794 |  |  | $ | 274,590 |  |  | $ | 32,964 |  |
_____________________________________ (1) Includes revenue of $2.4 million and $3.4 million from the Discontinuing Specialty Lab, for the three months ended June 30, 2023 and June 30, 2022, respectively. (2) Includes revenue of $3.9 million and $9.0 million from the Discontinuing Specialty Lab, for the six months ended June 30, 2023 and June 30, 2022, respectively. (3) Includes Adjusted EBITDA loss of $(0.9) million and Adjusted EBITDA of $0.4 million from the Discontinuing Specialty Lab for the three and six months ended June 30, 2022, respectively. (4) Includes the add back of start-up losses and investment in new services of $0.9 million and $1.7 million for the three and six months ended June 30, 2022, respectively . Presented below is a reconciliation of the Company’s segment measure to net loss:
|  | For the Three Months Ended June 30, |  |  | For the Six Months Ended June 30, |  |
|  | 2023 |  |  | 2022 |  |  | 2023 |  |  | 2022 |  |
Total |  | $ | 21,191 |  |  | $ | 16,513 |  |  | $ | 37,794 |  |  | $ | 32,964 |  |
Interest expense, net |  |  | (1,877 | ) |  |  | (1,518 | ) |  |  | (3,418 | ) |  |  | (2,610 | ) |
Income tax expense |  |  | (151 | ) |  |  | (831 | ) |  |  | (1,518 | ) |  |  | (2,100 | ) |
Depreciation and amortization |  |  | (11,398 | ) |  |  | (12,280 | ) |  |  | (21,953 | ) |  |  | (24,424 | ) |
Stock-based compensation |  |  | (11,090 | ) |  |  | (10,932 | ) |  |  | (24,125 | ) |  |  | (21,357 | ) |
Start-up losses and investment in new services |  |  | — |  |  |  | (885 | ) |  |  | — |  |  |  | (1,671 | ) |
Acquisition costs |  |  | (2,696 | ) |  |  | (519 | ) |  |  | (3,471 | ) |  |  | (986 | ) |
Fair value changes in financial instruments |  |  | 865 |  |  |  | 407 |  |  |  | (1,008 | ) |  |  | 2,856 |  |
Fair value changes in business acquisition contingencies |  |  | (353 | ) |  |  | 3,510 |  |  |  | 45 |  |  |  | 3,531 |  |
Expenses related to financing transactions |  |  | — |  |  |  | — |  |  |  | (4 | ) |  |  | (7 | ) |
Discontinuing Specialty Lab |  |  | (1,583 | ) | (1) |  | — |  |  |  | (4,019 | ) | (1) |  | — |  |
Other losses or expenses |  |  | (82 | ) |  |  | (1,216 | ) | (2) |  | (216 | ) |  |  | (1,483 | ) | (2)
Net loss |  | $ | (7,174 | ) |  | $ | (7,751 | ) |  | $ | (21,893 | ) |  | $ | (15,287 | ) |
__________________________ (1) Amounts consist of operating losses before depreciation related to the Discontinuing Specialty Lab. (2) Amounts include costs associated with the closing of a lab.

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 15 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-15 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//280/tableOfContent Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-26 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 34 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-34 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration